HQL News and Press, TeklaLife Sciences Investors From 02/20/24

2024-02-20 11:00:28 ET Summary Healthcare stocks have seen a better 2024 so far this year than the entire 2023 and 2022 years combined. If you go back 2 calendar years, the broad-based Health Care Select Sector SPDR® Fund ETF was still down slightly on a total-return basis. B...

2024-02-12 02:30:14 ET abrdn Life Sciences Investors ( NYSE: HQL ) declares $0.39/share quarterly dividend , 30% increase from prior dividend of $0.30. Forward yield 11.26% Payable March 28; for shareholders of record Feb. 22; ex-div Feb. 21. The Board has ...

PHILADELPHIA, PA / ACCESSWIRE / February 9, 2024 / abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) (collectively, the "Funds") each, a closed-end management investment company, announced today its Board of Trustees (each a "Boa...

2024-01-10 18:30:29 ET Summary For the second consecutive month, both equity (+3.42% on a NAV basis) and fixed income (+3.14%) CEFs on average posted plus-side returns. At month end, 9% of all CEFs traded at a premium to their NAV, with 9% of equity CEFs and 8% of fixed income CEF...

PHILADELPHIA, PA / ACCESSWIRE / January 10, 2024 / PHILADELPHIA, PA / ACCESSWIRE / January 10, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI, IFN, JEQ) (NYSE American:HQH, HQL, IAF, THQ, THW), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions...

2023-12-21 04:41:09 ET Summary abrdn Healthcare Investors continues to face pressure as healthcare and biotech sectors remain out of favor. HQH remains an attractive buy if one believes that the healthcare and biotech space can rebound in time and also offers a significant discoun...

2023-12-13 01:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-10 11:49:44 ET More on Tekla Life Sciences HQL: Hold Your Investments In This Healthcare CEF For Strong, Steady Yield Dividend scorecard for Tekla Life Sciences For further details see: Tekla Life Sciences declares $0.30 dividend

HQH , HQL , THQ , THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In addition, effective close of regular business, abrdn was approved as manager to four NYSE listed healthcare and biotech thematic cl...

Tekla Capital Management LLC (Tekla) announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds (the Funds). The Funds are: Tekla Healthcare Investors (HQH) Tekla Life Sciences Inve...